Cargando…
Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion
Secretory leukocyte peptidase inhibitor (SLPI) is a biomarker present in the respiratory tract that protects against tissue destruction and aids in wound healing. We examined whether SLPI in pleural effusion can be used to distinguish benign asbestos pleural effusion (BAPE) from early-stage malignan...
Autores principales: | Kishimoto, Takumi, Kojima, Yoko, Fujimoto, Nobukazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217519/ https://www.ncbi.nlm.nih.gov/pubmed/34155270 http://dx.doi.org/10.1038/s41598-021-92289-7 |
Ejemplares similares
-
Clinical Investigation of Benign Asbestos Pleural Effusion
por: Fujimoto, Nobukazu, et al.
Publicado: (2015) -
Retrospective investigation on diagnostic process for benign asbestos pleural effusion (BAPE) using checklist
por: Kishimoto, Takumi, et al.
Publicado: (2020) -
Lymphoproliferative disorder in pleural effusion in a subject with past asbestos exposure
por: Hara, Naofumi, et al.
Publicado: (2015) -
A retrospective study on radiological findings of diffuse pleural thickening with benign asbestos pleural effusion in Japanese cases
por: KISHIMOTO, Takumi, et al.
Publicado: (2021) -
MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion
por: Ak, Guntulu, et al.
Publicado: (2015)